BIIB logo

Biogen Inc. (BIIB) Cash From Financing

Annual CFF:

-$683.50M-$820.50M(-598.91%)
December 31, 2024

Summary

  • As of today, BIIB annual cash from financing is -$683.50 million, with the most recent change of -$820.50 million (-598.91%) on December 31, 2024.
  • During the last 3 years, BIIB annual cash from financing has risen by +$1.40 billion (+67.24%).
  • BIIB annual cash from financing is now -169.29% below its all-time high of $986.40 million, reached on December 31, 2015.

Performance

BIIB Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIIBcash flow metrics

Quarterly CFF:

-$130.20M-$118.50M(-1012.82%)
September 30, 2025

Summary

  • As of today, BIIB quarterly cash from financing is -$130.20 million, with the most recent change of -$118.50 million (-1012.82%) on September 30, 2025.
  • Over the past year, BIIB quarterly cash from financing has dropped by -$123.60 million (-1872.73%).
  • BIIB quarterly cash from financing is now -104.48% below its all-time high of $2.91 billion, reached on September 30, 2015.

Performance

BIIB Quarterly Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIIBcash flow metrics

TTM CFF:

-$157.00M-$123.60M(-370.06%)
September 30, 2025

Summary

  • As of today, BIIB TTM cash from financing is -$157.00 million, with the most recent change of -$123.60 million (-370.06%) on September 30, 2025.
  • Over the past year, BIIB TTM cash from financing has increased by +$1.19 billion (+88.33%).
  • BIIB TTM cash from financing is now -105.42% below its all-time high of $2.90 billion, reached on March 31, 2016.

Performance

BIIB TTM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIIBcash flow metrics

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

BIIB Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-598.9%-1872.7%+88.3%
3Y3 Years+67.2%+89.7%+91.0%
5Y5 Years-+90.1%+97.8%

BIIB Cash From Financing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-598.9%+67.2%-115.4%+89.7%-120.0%+91.2%
5Y5-Year-598.9%+87.0%-115.4%+90.1%-120.0%+97.8%
All-TimeAll-Time-169.3%+87.0%-104.5%+95.3%-105.4%+97.9%

BIIB Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2025
-
-$130.20M(-1012.8%)
-$157.00M(-370.1%)
Jun 2025
-
-$11.70M(+49.1%)
-$33.40M(+87.5%)
Mar 2025
-
-$23.00M(-391.1%)
-$266.90M(+61.0%)
Dec 2024
-$683.50M(-598.9%)
$7.90M(+219.7%)
-$683.50M(+49.2%)
Sep 2024
-
-$6.60M(+97.3%)
-$1.35B(-173.0%)
Jun 2024
-
-$245.20M(+44.2%)
-$492.90M(-90.3%)
Mar 2024
-
-$439.60M(+32.8%)
-$259.00M(-289.1%)
Dec 2023
$137.00M(+107.8%)
-$654.20M(-177.3%)
$137.00M(-82.5%)
Sep 2023
-
$846.10M(+7587.6%)
$783.60M(+159.1%)
Jun 2023
-
-$11.30M(+74.1%)
-$1.33B(+25.8%)
Mar 2023
-
-$43.60M(-473.7%)
-$1.79B(-1.5%)
Dec 2022
-$1.76B(+15.7%)
-$7.60M(+99.4%)
-$1.76B(-1.0%)
Sep 2022
-
-$1.26B(-168.1%)
-$1.74B(-42.3%)
Jun 2022
-
-$471.50M(-2757.6%)
-$1.22B(+7.1%)
Mar 2022
-
-$16.50M(-268.4%)
-$1.32B(+36.8%)
Dec 2021
-$2.09B(+60.4%)
$9.80M(+101.3%)
-$2.09B(+16.5%)
Sep 2021
-
-$746.50M(-32.2%)
-$2.50B(+18.5%)
Jun 2021
-
-$564.50M(+28.1%)
-$3.06B(+19.6%)
Mar 2021
-
-$785.00M(-95.7%)
-$3.81B(+27.7%)
Dec 2020
-$5.27B(-17.9%)
-$401.10M(+69.4%)
-$5.27B(+24.5%)
Sep 2020
-
-$1.31B(+0.0%)
-$6.99B(-9.8%)
Jun 2020
-
-$1.31B(+41.5%)
-$6.36B(+14.3%)
Mar 2020
-
-$2.25B(-6.1%)
-$7.43B(-26.7%)
Dec 2019
-
-$2.12B(-207.2%)
-$5.86B(-13.1%)
Sep 2019
-
-$689.00M(+71.0%)
-$5.18B(-16.0%)
Jun 2019
-
-$2.38B(-249.7%)
-$4.47B(+8.5%)
Mar 2019
-
-$679.30M(+52.7%)
-$4.88B(-9.2%)
Dec 2018
-$4.47B(-87.9%)
-$1.44B(-5825.1%)
-$4.47B(-19.5%)
Sep 2018
-
$25.10M(+100.9%)
-$3.74B(+1.2%)
Jun 2018
-
-$2.79B(-939.3%)
-$3.79B(-116.8%)
Mar 2018
-
-$268.60M(+62.1%)
-$1.75B(+26.6%)
Dec 2017
-$2.38B(-140.9%)
-$708.10M(-3531.3%)
-$2.38B(+0.5%)
Sep 2017
-
-$19.50M(+97.4%)
-$2.39B(+10.5%)
Jun 2017
-
-$751.00M(+16.7%)
-$2.67B(-38.1%)
Mar 2017
-
-$901.40M(-25.0%)
-$1.94B(-86.2%)
Dec 2016
-$987.80M(-200.1%)
-$721.20M(-139.9%)
-$1.04B(-226.1%)
Sep 2016
-
-$300.60M(-2143.3%)
-$319.00M(-111.0%)
Jun 2016
-
-$13.40M(-168.0%)
$2.89B(-0.3%)
Mar 2016
-
-$5.00M(-100.2%)
$2.90B(+17.3%)
Dec 2015
$986.40M(+230.5%)
-
-
Sep 2015
-
$2.91B(>+9900.0%)
$2.47B(+624.6%)
Jun 2015
-
-$3.54M(-104.4%)
-$471.17M(+40.4%)
Mar 2015
-
$80.76M(+115.7%)
-$789.99M(-4.5%)
Dec 2014
-$755.87M(-5.5%)
-$513.26M(-1361.3%)
-$755.87M(-226.6%)
Sep 2014
-
-$35.12M(+89.1%)
-$231.43M(+55.0%)
Jun 2014
-
-$322.36M(-380.6%)
-$514.83M(-41.7%)
Mar 2014
-
$114.88M(+927.4%)
-$363.23M(+49.3%)
Dec 2013
-$716.53M(+18.3%)
$11.18M(+103.5%)
-$716.53M(+3.6%)
Sep 2013
-
-$318.52M(-86.5%)
-$743.23M(-64.1%)
Jun 2013
-
-$170.76M(+28.4%)
-$452.96M(+35.3%)
Mar 2013
-
-$238.42M(-1435.8%)
-$699.64M(+20.3%)
Dec 2012
-$877.48M(-174.3%)
-$15.52M(+45.0%)
-$877.48M(+12.7%)
Sep 2012
-
-$28.25M(+93.2%)
-$1.00B(+6.6%)
Jun 2012
-
-$417.44M(-0.3%)
-$1.08B(-69.0%)
Mar 2012
-
-$416.26M(-191.5%)
-$636.29M(-98.9%)
Dec 2011
-$319.86M(+82.1%)
-$142.81M(-44.1%)
-$319.86M(-754.5%)
Sep 2011
-
-$99.13M(-552.5%)
$48.87M(+115.6%)
Jun 2011
-
$21.91M(+121.9%)
-$313.26M(+77.0%)
Mar 2011
-
-$99.83M(-144.2%)
-$1.36B(+23.7%)
Dec 2010
-$1.78B(-146.5%)
$225.93M(+149.0%)
-$1.78B(+33.4%)
Sep 2010
-
-$461.26M(+55.0%)
-$2.68B(-21.3%)
Jun 2010
-
-$1.03B(-96.0%)
-$2.21B(-87.2%)
Mar 2010
-
-$523.46M(+21.8%)
-$1.18B(-63.0%)
Dec 2009
-$724.15M(+41.4%)
-$669.59M(-7366.3%)
-$724.15M(-86.4%)
Sep 2009
-
$9.21M(+192.4%)
-$388.40M(-47.8%)
Jun 2009
-
$3.15M(+104.7%)
-$262.79M(+49.1%)
Mar 2009
-
-$66.93M(+80.0%)
-$516.07M(+58.3%)
Dec 2008
-$1.24B(-68.2%)
-$333.84M(-347.6%)
-$1.24B(-202.2%)
Sep 2008
-
$134.83M(+153.9%)
-$409.18M(+78.0%)
Jun 2008
-
-$250.13M(+68.2%)
-$1.86B(-20.3%)
Mar 2008
-
-$787.53M(-259.5%)
-$1.55B(-110.4%)
Dec 2007
-$735.22M
$493.65M(+137.5%)
-$735.22M(+36.6%)
DateAnnualQuarterlyTTM
Sep 2007
-
-$1.32B(-2145.7%)
-$1.16B(-654.0%)
Jun 2007
-
$64.41M(+164.0%)
-$153.89M(+25.9%)
Mar 2007
-
$24.40M(-64.4%)
-$207.66M(-39.9%)
Dec 2006
-
$68.57M(+122.0%)
-$148.41M(+0.5%)
Sep 2006
-
-$311.27M(-3027.1%)
-$149.10M(-182.2%)
Jun 2006
-
$10.63M(-87.3%)
$181.46M(+125.1%)
Mar 2006
-
$83.66M(+23.2%)
-$723.69M(+23.7%)
Dec 2005
-$948.52M(-110.3%)
$67.88M(+251.9%)
-$948.52M(+3.0%)
Sep 2005
-
$19.29M(+102.2%)
-$977.74M(+25.6%)
Jun 2005
-
-$894.52M(-533.6%)
-$1.31B(-88.3%)
Mar 2005
-
-$141.18M(-465.2%)
-$698.02M(-54.8%)
Dec 2004
-$450.96M(-1945.3%)
$38.66M(+112.2%)
-$450.96M(+5.5%)
Sep 2004
-
-$317.27M(-14.0%)
-$477.10M(-203.7%)
Jun 2004
-
-$278.23M(-362.8%)
-$157.09M(-224.6%)
Mar 2004
-
$105.88M(+745.9%)
$126.05M(+415.8%)
Dec 2003
$24.44M(-95.8%)
$12.52M(+357.4%)
$24.44M(+31.6%)
Sep 2003
-
$2.74M(-44.2%)
$18.58M(-3.6%)
Jun 2003
-
$4.91M(+14.7%)
$19.27M(-96.7%)
Mar 2003
-
$4.28M(-35.7%)
$579.19M(-0.8%)
Dec 2002
$584.06M(+2035.3%)
$6.66M(+94.2%)
$584.06M(+0.5%)
Sep 2002
-
$3.43M(-99.4%)
$581.39M(+0.0%)
Jun 2002
-
$564.83M(+6075.1%)
$581.19M(+1764.4%)
Mar 2002
-
$9.15M(+129.5%)
$31.17M(+14.0%)
Dec 2001
$27.35M(-94.2%)
$3.99M(+23.6%)
$27.35M(-94.3%)
Sep 2001
-
$3.23M(-78.2%)
$481.41M(+0.0%)
Jun 2001
-
$14.81M(+178.1%)
$481.22M(+2.7%)
Mar 2001
-
$5.33M(-98.8%)
$468.55M(-0.9%)
Dec 2000
$472.63M(+277.8%)
$458.05M(>+9900.0%)
$472.63M(+2532.0%)
Sep 2000
-
$3.04M(+41.7%)
$17.96M(-5.9%)
Jun 2000
-
$2.14M(-77.2%)
$19.07M(+1.0%)
Mar 2000
-
$9.40M(+178.7%)
$18.88M(-84.9%)
Dec 1999
$125.11M(+4990.1%)
$3.37M(-18.7%)
$125.11M(+1.6%)
Sep 1999
-
$4.15M(+113.5%)
$123.19M(+4.5%)
Jun 1999
-
$1.95M(-98.3%)
$117.89M(+1.8%)
Mar 1999
-
$115.64M(+7908.6%)
$115.79M(>+9900.0%)
Dec 1998
-
$1.44M(+225.9%)
$538.00K(-98.7%)
Sep 1998
-
-$1.15M(-644.8%)
$40.79M(-2.7%)
Jun 1998
-
-$154.00K(-139.0%)
$41.94M(+83.2%)
Mar 1998
-
$395.00K(-99.1%)
$22.89M(-65.3%)
Dec 1997
$2.46M(-96.2%)
$41.70M(>+9900.0%)
$65.90M(+64.4%)
Sep 1997
-
$0.00(+100.0%)
$40.07M(-21.8%)
Jun 1997
-
-$19.20M(-144.2%)
$51.27M(-38.7%)
Mar 1997
-
$43.40M(+173.4%)
$83.67M(+61.6%)
Dec 1996
$64.46M(+885.0%)
$15.87M(+41.7%)
$51.77M(-16.0%)
Sep 1996
-
$11.20M(-15.2%)
$61.65M(-13.0%)
Jun 1996
-
$13.20M(+14.8%)
$70.85M(+18.6%)
Mar 1996
-
$11.50M(-55.3%)
$59.75M(-19.2%)
Dec 1995
$6.54M(-60.0%)
$25.75M(+26.2%)
$73.95M(+50.8%)
Sep 1995
-
$20.40M(+871.4%)
$49.05M(+46.6%)
Jun 1995
-
$2.10M(-91.8%)
$33.45M(-14.3%)
Mar 1995
-
$25.70M(+2941.4%)
$39.05M(+151.2%)
Dec 1994
$16.37M(+212.0%)
$845.00K(-82.4%)
$15.54M(-15.5%)
Sep 1994
-
$4.80M(-37.7%)
$18.40M(+21.9%)
Jun 1994
-
$7.70M(+250.0%)
$15.10M(+69.7%)
Mar 1994
-
$2.20M(-40.5%)
$8.90M(+14.1%)
Dec 1993
$5.25M(+241.2%)
$3.70M(+146.7%)
$7.80M(-28.4%)
Sep 1993
-
$1.50M(0.0%)
$10.90M(-5.2%)
Jun 1993
-
$1.50M(+36.4%)
$11.50M(+8.5%)
Mar 1993
-
$1.10M(-83.8%)
$10.60M(+6.0%)
Dec 1992
$1.54M(-97.2%)
$6.80M(+223.8%)
$10.00M(-88.7%)
Sep 1992
-
$2.10M(+250.0%)
$88.30M(-0.5%)
Jun 1992
-
$600.00K(+20.0%)
$88.70M(+1.1%)
Mar 1992
-
$500.00K(-99.4%)
$87.70M(+1.4%)
Dec 1991
$54.72M(+3140.0%)
$85.10M(+3304.0%)
$86.50M(>+9900.0%)
Sep 1991
-
$2.50M(+725.0%)
$100.00K(+105.3%)
Jun 1991
-
-$400.00K(+42.9%)
-$1.90M(-18.8%)
Mar 1991
-
-$700.00K(+46.2%)
-$1.60M(+11.1%)
Dec 1990
-$1.80M(-102.8%)
-$1.30M(-360.0%)
-$1.80M(-260.0%)
Sep 1990
-
$500.00K(+600.0%)
-$500.00K(+50.0%)
Jun 1990
-
-$100.00K(+88.9%)
-$1.00M(-11.1%)
Mar 1990
-
-$900.00K
-$900.00K
Dec 1989
$64.50M
-
-

FAQ

  • What is Biogen Inc. annual cash from financing?
  • What is the all-time high annual cash from financing for Biogen Inc.?
  • What is Biogen Inc. annual cash from financing year-on-year change?
  • What is Biogen Inc. quarterly cash from financing?
  • What is the all-time high quarterly cash from financing for Biogen Inc.?
  • What is Biogen Inc. quarterly cash from financing year-on-year change?
  • What is Biogen Inc. TTM cash from financing?
  • What is the all-time high TTM cash from financing for Biogen Inc.?
  • What is Biogen Inc. TTM cash from financing year-on-year change?

What is Biogen Inc. annual cash from financing?

The current annual cash from financing of BIIB is -$683.50M

What is the all-time high annual cash from financing for Biogen Inc.?

Biogen Inc. all-time high annual cash from financing is $986.40M

What is Biogen Inc. annual cash from financing year-on-year change?

Over the past year, BIIB annual cash from financing has changed by -$820.50M (-598.91%)

What is Biogen Inc. quarterly cash from financing?

The current quarterly cash from financing of BIIB is -$130.20M

What is the all-time high quarterly cash from financing for Biogen Inc.?

Biogen Inc. all-time high quarterly cash from financing is $2.91B

What is Biogen Inc. quarterly cash from financing year-on-year change?

Over the past year, BIIB quarterly cash from financing has changed by -$123.60M (-1872.73%)

What is Biogen Inc. TTM cash from financing?

The current TTM cash from financing of BIIB is -$157.00M

What is the all-time high TTM cash from financing for Biogen Inc.?

Biogen Inc. all-time high TTM cash from financing is $2.90B

What is Biogen Inc. TTM cash from financing year-on-year change?

Over the past year, BIIB TTM cash from financing has changed by +$1.19B (+88.33%)
On this page